BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26756273)

  • 1. Genetics of psychosis of Alzheimer disease.
    Shah C; DeMichele-Sweet MA; Sweet RA
    Am J Med Genet B Neuropsychiatr Genet; 2017 Jan; 174(1):27-35. PubMed ID: 26756273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide association study of Alzheimer's disease with psychotic symptoms.
    Hollingworth P; Sweet R; Sims R; Harold D; Russo G; Abraham R; Stretton A; Jones N; Gerrish A; Chapman J; Ivanov D; Moskvina V; Lovestone S; Priotsi P; Lupton M; Brayne C; Gill M; Lawlor B; Lynch A; Craig D; McGuinness B; Johnston J; Holmes C; Livingston G; Bass NJ; Gurling H; McQuillin A; ; ; Holmans P; Jones L; Devlin B; Klei L; Barmada MM; Demirci FY; DeKosky ST; Lopez OL; Passmore P; Owen MJ; O'Donovan MC; Mayeux R; Kamboh MI; Williams J
    Mol Psychiatry; 2012 Dec; 17(12):1316-27. PubMed ID: 22005930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of psychosis in Alzheimer's disease: a review.
    DeMichele-Sweet MA; Sweet RA
    J Alzheimers Dis; 2010; 19(3):761-80. PubMed ID: 20157235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide copy-number variation study of psychosis in Alzheimer's disease.
    Zheng X; Demirci FY; Barmada MM; Richardson GA; Lopez OL; Sweet RA; Kamboh MI; Feingold E
    Transl Psychiatry; 2015 Jun; 5(6):e574. PubMed ID: 26035058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E and alpha-1-antichymotrypsin genotypes do not predict time to psychosis in Alzheimer's disease.
    Sweet RA; Kamboh MI; Wisniewski SR; Lopez OL; Klunk WE; Kaufer DI; DeKosky ST
    J Geriatr Psychiatry Neurol; 2002; 15(1):24-30. PubMed ID: 11936240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease.
    DeMichele-Sweet MAA; Klei L; Creese B; Harwood JC; Weamer EA; McClain L; Sims R; Hernandez I; Moreno-Grau S; Tárraga L; Boada M; Alarcón-Martín E; Valero S; ; Liu Y; Hooli B; Aarsland D; Selbaek G; Bergh S; Rongve A; Saltvedt I; Skjellegrind HK; Engdahl B; Stordal E; Andreassen OA; Djurovic S; Athanasiu L; Seripa D; Borroni B; Albani D; Forloni G; Mecocci P; Serretti A; De Ronchi D; Politis A; Williams J; Mayeux R; Foroud T; Ruiz A; Ballard C; Holmans P; Lopez OL; Kamboh MI; Devlin B; Sweet RA
    Mol Psychiatry; 2021 Oct; 26(10):5797-5811. PubMed ID: 34112972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic risk for schizophrenia and psychosis in Alzheimer disease.
    DeMichele-Sweet MAA; Weamer EA; Klei L; Vrana DT; Hollingshead DJ; Seltman HJ; Sims R; Foroud T; Hernandez I; Moreno-Grau S; Tárraga L; Boada M; Ruiz A; Williams J; Mayeux R; Lopez OL; Sibille EL; Kamboh MI; Devlin B; Sweet RA
    Mol Psychiatry; 2018 Apr; 23(4):963-972. PubMed ID: 28461698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased familial risk and genomewide significant linkage for Alzheimer's disease with psychosis.
    Hollingworth P; Hamshere ML; Holmans PA; O'Donovan MC; Sims R; Powell J; Lovestone S; Myers A; DeVrieze FW; Hardy J; Goate A; Owen M; Williams J
    Am J Med Genet B Neuropsychiatr Genet; 2007 Oct; 144B(7):841-8. PubMed ID: 17492769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosis in Alzheimer's disease.
    Murray PS; Kumar S; Demichele-Sweet MA; Sweet RA
    Biol Psychiatry; 2014 Apr; 75(7):542-52. PubMed ID: 24103379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease.
    Qian W; Fischer CE; Schweizer TA; Munoz DG
    Curr Alzheimer Res; 2018; 15(2):187-194. PubMed ID: 28847281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linkage analysis of Alzheimer disease with psychosis.
    Bacanu SA; Devlin B; Chowdari KV; DeKosky ST; Nimgaonkar VL; Sweet RA
    Neurology; 2002 Jul; 59(1):118-20. PubMed ID: 12105318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease.
    Sweet RA; Devlin B; Pollock BG; Sukonick DL; Kastango KB; Bacanu SA; Chowdari KV; DeKosky ST; Ferrell RE
    Mol Psychiatry; 2005 Nov; 10(11):1026-36. PubMed ID: 16027741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer's disease.
    Creese B; Vassos E; Bergh S; Athanasiu L; Johar I; Rongve A; Medbøen IT; Vasconcelos Da Silva M; Aakhus E; Andersen F; Bettella F; Braekhus A; Djurovic S; Paroni G; Proitsi P; Saltvedt I; Seripa D; Stordal E; Fladby T; Aarsland D; Andreassen OA; Ballard C; Selbaek G;
    Transl Psychiatry; 2019 Oct; 9(1):273. PubMed ID: 31641104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between 5-HT(2A) receptor polymorphism and psychotic symptoms in Alzheimer's disease.
    Nacmias B; Tedde A; Forleo P; Piacentini S; Guarnieri BM; Bartoli A; Ortenzi L; Petruzzi C; Serio A; Marcon G; Sorbi S
    Biol Psychiatry; 2001 Sep; 50(6):472-5. PubMed ID: 11566166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease.
    Panza F; Frisardi V; Seripa D; D'Onofrio G; Santamato A; Masullo C; Logroscino G; Solfrizzi V; Pilotto A
    Ageing Res Rev; 2012 Jan; 11(1):87-103. PubMed ID: 21763789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic association between APOE*4 and neuropsychiatric symptoms in patients with probable Alzheimer's disease is dependent on the psychosis phenotype.
    Christie D; Shofer J; Millard SP; Li E; Demichele-Sweet MA; Weamer EA; Kamboh MI; Lopez OL; Sweet RA; Tsuang D
    Behav Brain Funct; 2012 Dec; 8():62. PubMed ID: 23270420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased familial risk of the psychotic phenotype of Alzheimer disease.
    Sweet RA; Nimgaonkar VL; Devlin B; Lopez OL; DeKosky ST
    Neurology; 2002 Mar; 58(6):907-11. PubMed ID: 11914406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
    Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease.
    Coon KD; Myers AJ; Craig DW; Webster JA; Pearson JV; Lince DH; Zismann VL; Beach TG; Leung D; Bryden L; Halperin RF; Marlowe L; Kaleem M; Walker DG; Ravid R; Heward CB; Rogers J; Papassotiropoulos A; Reiman EM; Hardy J; Stephan DA
    J Clin Psychiatry; 2007 Apr; 68(4):613-8. PubMed ID: 17474819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting Complex and Multifactorial Nature of Alzheimer's Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective.
    Talwar P; Sinha J; Grover S; Rawat C; Kushwaha S; Agarwal R; Taneja V; Kukreti R
    Mol Neurobiol; 2016 Sep; 53(7):4833-64. PubMed ID: 26351077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.